NASDAQ: SIGA
Siga Technologies Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their SIGA stock forecasts and price targets.

Forecast return on equity

Is SIGA forecast to generate an efficient return?

Company
46.55%
Industry
105.51%
Market
131.22%
SIGA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SIGA forecast to generate an efficient return on assets?

Company
43.79%
Industry
17.8%
SIGA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SIGA earnings per share forecast

What is SIGA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.15
Avg 2 year Forecast
$1.07

SIGA revenue forecast

What is SIGA's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$67.6M+26.05%
Avg 2 year Forecast
$165.3M+208.04%
SIGA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SIGA revenue growth forecast

How is SIGA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
26.05%
Industry
9.39%
Market
20.74%
SIGA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SIGA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SIGA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SIGA$2.94N/AN/A
ORGO$1.67$5.00+199.40%Buy
CRDL$1.86$9.50+410.75%Strong Buy
DERM$7.91$14.00+76.99%Strong Buy
OGI$1.26N/AN/A

Siga Technologies Stock Forecast FAQ

What is SIGA's earnings growth forecast for 2026-2027?

(NASDAQ: SIGA) Siga Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 28.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,116.47%.

Siga Technologies's earnings in 2026 is -$2,786,555.On average, 3 Wall Street analysts forecast SIGA's earnings for 2026 to be $10,993,007, with the lowest SIGA earnings forecast at $10,561,908, and the highest SIGA earnings forecast at $11,316,330.

In 2027, SIGA is forecast to generate $76,951,046 in earnings, with the lowest earnings forecast at $73,933,358 and the highest earnings forecast at $79,214,312.

If you're new to stock investing, here's how to buy Siga Technologies stock.

What is SIGA's revenue growth forecast for 2026-2027?

(NASDAQ: SIGA) Siga Technologies's forecast annual revenue growth rate of 26.05% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.39%, and it is also forecast to beat the US market's average forecast revenue growth rate of 20.74%.

Siga Technologies's revenue in 2026 is $53,658,917.On average, 3 Wall Street analysts forecast SIGA's revenue for 2026 to be $4,859,842,941, with the lowest SIGA revenue forecast at $4,669,297,494, and the highest SIGA revenue forecast at $5,002,823,875.

In 2027, SIGA is forecast to generate $11,876,039,558 in revenue, with the lowest revenue forecast at $11,410,453,398 and the highest revenue forecast at $12,225,229,177.

What is SIGA's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SIGA) forecast ROA is 43.79%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 17.8%.

What is SIGA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SIGA) Siga Technologies's current Earnings Per Share (EPS) is -$0.04. On average, analysts forecast that SIGA's EPS will be $0.15 for 2026, with the lowest EPS forecast at $0.15, and the highest EPS forecast at $0.16. In 2027, SIGA's EPS is forecast to hit $1.07 (min: $1.03, max: $1.10).

What is SIGA's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SIGA) forecast ROE is 46.55%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.